| value |
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1459839/0001459839-26-000049.txt","as_of":"2026-04-22T03:03:32.063787+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1459839/0001459839-26-000049.txt","company":"SI-BONE, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1459839/0001459839-26-000049.txt","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_8b10615e6f4046c3","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1459839/0001459839-26-000049.txt","content_type":"text/plain","enriched_at":"2026-04-22T03:29:33.373785+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"sibn-20260420","final_url":"https://www.sec.gov/Archives/edgar/data/1459839/0001459839-26-000049.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1459839/0001459839-26-000049.txt","source_event_id":"evt_8f18ce1a3b4f","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"DEF 14A","fp":"7e8bd9513c8d1f89","kind":"sec_filing","published_at":"20260421","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-21","2026-06-04","2025-10-01","2024"],"entities":[{"asset_class":"equity","name":"SI-BONE, Inc.","relevance":"high","symbol":"SIBN","type":"issuer"},{"asset_class":"person","name":"Laura Francis","relevance":"medium","symbol":"","type":"person"},{"asset_class":"platform","name":"virtualshareholdermeeting.com/SIBN2026","relevance":"medium","symbol":"","type":"website"}],"event_type":"listing","information_gaps":["The specific agenda items/purposes of the Annual Meeting are referenced but not included in the provided text (the section listing the items of business is truncated).","The filing\u2019s \u201cAmendment No.\u201d is shown as \u201c__\u201d (not specified in the provided text).","No explicit description of what changed versus a prior known state is provided in the supplied content; only the fact of the DEF 14A filing is evidenced.","No details are provided here on director nominees, executive compensation, or voting proposals beyond the referenced but omitted \u201cmore fully described\u201d section."],"key_facts":["Form DEF 14A is identified as a \u201cDefinitive Proxy Statement\u201d in the filing header.","The filing is for SI-BONE, Inc. and includes an \u201cInvitation to 2026 Annual Meeting of Stockholders.\u201d","The Annual Meeting is scheduled for Thursday, June 4, 2026 at 8:00 a.m. Pacific Time.","The Annual Meeting is described as \u201ccompletely virtual\u201d and conducted via live webcast.","Stockholders can attend, submit questions, and vote online during the meeting at www.virtualshareholdermeeting.com/SIBN2026 using a 16-digit control number from the proxy card or voting instruction card.","Without the 16-digit control number, attendees can only enter in \u201clisten-only\u201d mode and cannot submit questions or vote.","The CEO letter states 2025 highlights including: worldwide revenue of $200.9 million (~20% annual increase), over 2,400 U.S. physicians performing nearly 22,000 procedures, and over 140,000 procedures worldwide since inception.","The CEO letter states 2025 financial metrics: net loss of $18.9 million (~39% annual improvement) and positive Adjusted EBITDA of $8.9 million (compared to a loss of $5.1 million in 2024).","The CEO letter states year-end cash and equivalents of $147.8 million.","The CEO letter states iFuse TORQ was launched across Europe.","The CEO letter states a \u201cNew Technology Add-On Payment\u201d was granted effective October 1, 2025 for incremental reimbursement to hospitals for eligible inpatient procedures using iFuse TORQ TNT."],"numeric_claims":[{"label":"Annual Meeting date","value":"2026-06-04"},{"label":"Annual Meeting time (Pacific)","value":"8:00 a.m."},{"label":"Worldwide revenue (2025)","value":"$200.9 million"},{"label":"Worldwide revenue growth","value":"~20%"},{"label":"U.S. physicians (2025)","value":"over 2,400"},{"label":"Procedures (2025, U.S.)","value":"nearly 22,000"},{"label":"Procedures since inception","value":"over 140,000"},{"label":"Net loss (2025)","value":"$18.9 million"},{"label":"Net loss improvement","value":"~39%"},{"label":"Adjusted EBITDA (2025)","value":"$8.9 million"},{"label":"Adjusted EBITDA (2024)","value":"loss of $5.1 million"},{"label":"Cash and equivalents (year-end)","value":"$147.8 million"},{"label":"iFuse TORQ Europe launch","value":"stated as launched across Europe (date not specified)"},{"label":"New Technology Add-On Payment effective date","value":"2025-10-01"}],"primary_claim":"SI-BONE, Inc. filed a definitive proxy statement (Form DEF 14A) for its 2026 Annual Meeting of Stockholders, scheduled for June 4, 2026 at 8:00 a.m. Pacific Time (virtual).","relevance_score":0.55,"sentiment":"mixed","source_quality":"high","summary":"SI-BONE, Inc. filed a definitive proxy statement on Form DEF 14A for its 2026 Annual Meeting of Stockholders. The filing includes an invitation letter and describes 2025 performance highlights and the virtual meeting logistics.","topics":["SEC filing","proxy statement","annual meeting","virtual meeting","corporate performance highlights","Adjusted EBITDA","cash and equivalents","iFuse TORQ","technology add-on payment"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form DEF 14A \u00b7 SI-BONE, Inc. \u00b7 Filed 20260421","ticker":"SIBN","tickers":["SIBN"],"title":"SIBN filed DEF 14A","url":"https://www.sec.gov/Archives/edgar/data/1459839/0001459839-26-000049.txt"}... |